Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

4420 results about "Expression vector" patented technology

An expression vector, otherwise known as an expression construct, is usually a plasmid or virus designed for gene expression in cells. The vector is used to introduce a specific gene into a target cell, and can commandeer the cell's mechanism for protein synthesis to produce the protein encoded by the gene. Expression vectors are the basic tools in biotechnology for the production of proteins.

Ornithine decarboxylase mutant, genetically engineered bacterium for expressing ornithine decarboxylase mutant and application of ornithine decarboxylase mutant

The invention belongs to the technical field of gene engineering and enzyme engineering, and particularly relates to an ornithine decarboxylase mutant as well as a coding gene, an expression vector, a recombinant strain and application thereof. The ornithine decarboxylase mutant is obtained by mutating wild ornithine decarboxylase ODC10 of which the amino acid sequence is shown as SEQ ID NO.1, the catalytic activity of the obtained mutant is improved, and the biosynthesis efficiency of 1, 4-butanediamine is favorably improved. The recombinant strain for expressing the ornithine decarboxylase mutant constructed by the invention can efficiently synthesize 1, 4-butanediamine, and the molar conversion rate of ornithine is remarkably improved, so that the production benefit is improved, and the production cost is reduced.
Owner:TIANJIN UNIV OF SCI & TECH

Recombinant humanized XVII type collagen as well as expression vector and genetically engineered bacterium thereof

The invention discloses a recombinant humanized XVII type collagen as well as an expression vector and a genetically engineered bacterium thereof. Four functional fragments with high activity are obtained through screening, one of the fragments is optimized and then combined according to a certain sequence to obtain recombinant humanized XVII type collagen JYC1703, or one of the fragments is optimized and then combined according to a certain sequence, and GPP sequences are fused at an amino terminal and a carboxyl terminal respectively to obtain recombinant humanized XVII type collagen JYC1701 and JYC1702, and the recombinant humanized XVII type collagen JYC1701 and JYC1702 are combined according to a certain sequence to obtain the recombinant humanized XVII type collagen JYC1701 and JYC1702. After codon optimization, amplifying and cloning into an expression vector, transforming into pichia pastoris competent cells after enzyme digestion linearization, and screening high-copy recombinants through G418 resistance gradient, so as to obtain pichia pastoris genetically engineered bacteria for expressing recombinant humanized XVII type collagen. The recombinant humanized XVII type collagen JYC1701, JYC1702 and JYC1703 disclosed by the invention show excellent functions of promoting cell adhesion, cell proliferation and cell migration, and are suitable for preparing products such as skin care products or medical instruments and the like.
Owner:ZHEJIANG ZHUJI JUYUAN BIOTECHNOLOGY CO LTD

Application of wheat TaPND gene

The present invention relates to the fields of genetic engineering and plant genetic breeding, and specifically to the application of wheat TaPND gene. In the present invention, by taking gene TaPND as a target, designing a sgRNA sequence based on CRISPR / Cas9, connecting a DNA fragment containing the encoding sgRNA sequence to a vector carrying CRISPR / Cas, a plant binary expression vector capable of knocking out the TaPND gene in wheat is constructed; by genetically transforming wheat, offspring with TaPND gene knockout are obtained, and wheat mutants with early flowering time are obtained. Experiments have confirmed that transgenic wheat with TaPND gene knockout achieves the advancement of wheat flowering time. The technical scheme of the present invention provides a practical method for realizing rapid wheat breeding using genetic engineering technology, which has important breeding application value and broad market application prospects.
Owner:SHANDONG UNIV

Protein targeted degradation system capable of being regulated and controlled in programmable mode, construction and application of protein targeted degradation system

ActiveCN119495366AEfficient degradationPrecise regulation of degradationProteomicsGenomicsProtein targetDanoprevir
The invention discloses a modified Trim 21 (delta Trim 21)-based target protein degradation control system, which takes a modified protein delta Trim 21 degradation system as a basis, takes blue light, abscisic acid, Danoprevir and / or MK-5172 as inductors, controls the combination of target protein and delta Trim 21 by introducing and modifying a controllable protein dimerization system on the basis of the modified protein delta Trim 21 degradation system, and improves the target protein degradation control system. The protein targeted degradation capable of being modularly regulated and controlled is carried out. Two regulation and control modules, namely a target protein recognition module and a degradation module based on E3 ubiquitinase, are constructed by splitting and recombining a controllable protein dimerization system and a delta Trim 21 structural domain. The invention also discloses a degradation device comprising the system. The invention also discloses a method for accurately regulating endogenous proteins (degradation of proteins related to tumorigenesis) by using the programmable regulation type modular protein degradation device, so as to achieve the effect of specifically killing tumors. The invention also provides a eukaryotic expression vector and a regulation method of the programmable regulation type protein targeted degradation device.
Owner:EAST CHINA NORMAL UNIV

Peroxidase AniUPO or mutant thereof, application of peroxidase AniUPO or mutant thereof in synthesis of alpha-hydroxyl beta-ketoester derivative and method for synthesizing alpha-hydroxyl beta-ketoester derivative

The invention relates to peroxidase AniUPO or a mutant of the peroxidase AniUPO, application of the peroxidase AniUPO in synthesis of alpha-hydroxyl beta-ketoester derivatives and a method for synthesizing the alpha-hydroxyl beta-ketoester derivatives, and belongs to the field of enzyme engineering. The invention provides a peroxidase AniUPO mutant, which is an amino acid sequence obtained by taking wild type peroxidase AniUPO with an amino acid sequence as shown in SEQ ID NO.1 as a parent and mutating the wild type peroxidase AniUPO with the amino acid sequence as shown in SEQ ID NO.1. The invention also provides a DNA (Deoxyribonucleic Acid) molecule for coding the peroxidase AniUPO mutant, an expression vector, a host cell and a method for synthesizing the chiral alpha-hydroxyl beta-ketone ester derivative. Compared with a wild type, the peroxidase mutant has the advantages of higher catalytic activity and better selectivity, applicable substrate types can be expanded to various cyclic and non-cyclic beta-ketone ester substrates, expensive catalysts and ligands are not needed, reaction conditions are mild, and potential industrial application prospects are achieved.
Owner:THE WEST CHINA SECOND UNIV HOSPITAL OF SICHUAN

Method for editing cattle gene based on Pro-iCHI

The invention belongs to the technical field of molecular biology and genetics, and particularly relates to a method for editing cattle genes based on Pro-iCHI. The invention provides a method for editing cattle genes based on Pro-iCHI, which comprises the following steps: transiently expressing protamine in cattle AG-haESCs after gene editing, and injecting into mature oocytes to obtain reconstructed embryos. The protamine can remove abnormal DNA methylation generated by an oocyte cytoplasm injection haploid stem cell technology, cell nucleuses are compressed into a sperm-like structure, the obtained bovine Pro-iCHI embryo can smoothly develop into a blastocyst, and the ratio of the blastocyst to the blastocyst obtained by in-vitro fertilization is equivalent. Moreover, the protamine coding gene is inserted into the saccharomyces cerevisiae protein expression vector and then is subjected to transient expression, so that the protamine coding gene cannot be integrated into a genome to cause insertion of an exogenous gene while abnormal DNA methylation is erased.
Owner:INNER MONGOLIA UNIVERSITY

Cellular reprogramming to reverse aging and promote organ and tissue regeneration

ActiveUS12274733B2Senses disorderNervous disorderTissue repairVaccine virus
Provided herein are engineered nucleic acids (e.g., expression vectors, including viral vectors, such as lentiviral vectors, adenoviral vectors, AAV vectors, herpes viral vectors, and retroviral vectors) that encode OCT4; KLF4; SOX2; or any combination thereof that are useful, for example, in inducing cellular reprogramming, tissue repair, tissue regeneration, organ regeneration, reversing aging, or any combination thereof. Also provided herein are recombinant viruses (e.g., lentiviruses, alphaviruses, vaccinia viruses, adenoviruses, herpes viruses, retroviruses, or AAVs) comprising the engineered nucleic acids (e.g., engineered nucleic acids), engineered cells, compositions comprising the engineered nucleic acids, the recombinant viruses, engineered cells, engineered proteins, chemical agents that are capable of activating expression of OCT4; KLF4; SOX2; or any combination thereof, an engineered protein selected from the group consisting of OCT4; KLF4; SOX2; or any combination thereof, an antibody capable of activating expression of OCT4; KLF4; SOX2; or any combination thereof, and methods of treating a (e.g., ocular disease), preventing a disease (e.g., ocular disease), regulating (e.g., inducing or inducing and then stopping) cellular reprogramming, regulating tissue repair, regulating tissue regeneration, or any combination thereof).
Owner:PRESIDENT & FELLOWS OF HARVARD COLLEGE

Genetically engineered algae capable of resisting aquatic pathogenic bacteria as well as construction method and application of genetically engineered algae

The invention discloses a genetically engineered algae capable of resisting aquatic pathogenic bacteria as well as a construction method and application thereof, and is characterized in that the genetically engineered algae is phaeodactylum tricornutum into which cell wall energizing plasmids pPha-T1-J48054-eGFP-Linker-Q4 or pPha-T1-J48054-eGFP-Linker-Q6 are introduced, and the preparation method of the genetically engineered algae comprises the following steps: taking genome DNA of the phaeodactylum tricornutum as a template; the method comprises the following steps: constructing a directional expression plasmid pPha-T1-J48054-eGFP by amplifying a Phatr3J48054 coding sequence, inserting Q4 and Q6 coding sequences into the downstream of the eGFP of a directional expression vector, constructing a cell wall energizing plasmid, electrically transforming the cell wall energizing plasmid into phaeodactylum tricornutum, coating an f / 2 plate culture medium with transformed phaeodactylum tricornutum cells for culturing, screening positive algae strains, and screening the positive algae strains. The feed additive has the advantage of inhibiting or killing aquatic pathogenic bacteria.
Owner:NINGBO UNIV

Moso bamboo PeSND1 gene, application thereof and plant vector

PendingCN119082134AStem thickness changesChanges in cell wall thicknessClimate change adaptationPlant peptidesBiotechnologyNucleotide
The invention discloses a phyllostachys pubescens PeSND1 gene, application thereof and a plant vector, belongs to the technical field of plant molecular biology, and comprises a protein consisting of a nucleotide sequence SEQ ID NO.1 and an amino acid sequence SEQ ID NO.2 in a sequence table. The invention provides a moso bamboo PeSND1 gene for regulating and controlling secondary cell wall components as well as an encoding protein and application of the moso bamboo PeSND1 gene. The PeSND1 gene overexpression vector is transferred into wild dendrocalamus latiflorus through an agrobacterium-mediated method, and the result shows that compared with a wild strain, the stem diameter, the cell wall thickness, the lignin content and the cellulose content of an overexpression strain are obviously changed. The result provides a theoretical basis for research on bamboo secondary cell wall component regulation and control.
Owner:RES INST OF SUBTROPICAL FORESTRY CHINESE ACAD OF FORESTRY

Mammalian cell expression vector, expression plasmid and expression system

The invention discloses a mammalian cell expression vector, an expression plasmid and an expression system. The expression vector sequentially comprises the following elements: (a) a promoter; (b) a Kozak sequence; (c) a polyadenine sequence, the polyadenine sequence sequentially comprises a bGH PolyA sequence and a 5 'UTR PolyA sequence, the nucleotide sequence of the bGH PolyA sequence is as shown in SEQ ID NO.5, and the nucleotide sequence of the 5' UTR PolyA sequence is as shown in SEQ ID NO.6; (d) copying the start site; and (e) screening marker genes. According to the present invention, the expression vector is optimized by the expression element, such that the exogenous gene can be conveniently, efficiently and flexibly inserted and edited by the expression vector so as to achieve the stable extracellular or intracellular expression of the exogenous protein, and the expression efficiency of the exogenous protein can be improved by carrying out the expression plasmid construction based on the expression vector; and more efficient expression and purification of the foreign protein are realized.
Owner:INST OF HEALTH & MEDICINE HEFEI COMPREHENSIVE NAT SCI CENT

Application of SlMADS1 gene in regulating lycopene content

The invention discloses application of an SlMADS1 gene in regulating lycopene content, and belongs to the technical field of plant genetic engineering and genetic modification. According to the invention, an editing target site of an SlMADS1 gene is designed, a pCAMBIA1300-CRISPR / Cas9-gRNA expression vector is constructed, the expression vector is transformed into a tomato material with low lycopene content in fruits by using an agrobacterium-mediated method, and a positive T0-generation transgenic tomato plant is obtained through antibiotic screening; and carrying out selfing on the T0 generation to obtain T1 generation plants, and screening plants which do not contain exogenous transgenic components, have homozygous mutation of the SlMADS1 gene and have high lycopene content in fruits from the T1 generation, so as to obtain the high-lycopene material. According to the invention, the content of lycopene in tomato fruits can be obviously increased, and the method has a good application prospect in high-quality molecular breeding of tomatoes.
Owner:HORTICULTURE INST OF XINJIANG ACAD OF AGRI SCI

A plant virus expression vector and its application

The present invention provides a structure, sequence, construction method and application of a plant virus vector in plant gene expression. The key point is that the plant virus vector contains a structure of 35S promoter, 560bp sequence at the 5' end of the tobacco rattle virus TRV2 genome, NC cloning frame, 395bp sequence at the 3' end of the tobacco rattle virus TRV2 genome, and Nos terminator. The target gene is quickly cloned into the vector through a one-step ligation reaction of Nimble cloning (NC cloning), and efficient gene expression and gene editing are performed in plants. The vector provided by the present invention can clone plant genes simply, quickly and efficiently, and is convenient for plant gene expression, silencing or editing research.
Owner:INST OF TROPICAL BIOSCI & BIOTECH CHINESE ACADEMY OF TROPICAL AGRI SCI

Tyrosine sulfated recombinant hirudin as well as preparation method and application thereof

The invention relates to the technical field of gene engineering, in particular to tyrosine sulfated recombinant hirudin as well as a preparation method and application thereof. In order to improve the safety and synthesis yield of the recombinant hirudin and reduce the production cost, the tyrosine sulfated recombinant hirudin is successfully prepared through an algae expression vector.
Owner:BEIJING YUANQI HESHENG TECHNOLOGY CO LTD

GP130 antigen-binding antibodies

PCT designated stage expiredWO2025017127A1AntipyreticAnalgesicsAntigen bindingHumanized antibody
Gp130 antigen-binding antibodies are disclosed which inhibit IL-6, IL-11, OSM, LIF, CNTF, CT-1 mediated signal and bind to the cytokine binding region. Also disclosed are nucleic acids and expression vectors encoding, compositions comprising, humanised antibodies and therapeutic methods using, the Gp130 antigen-binding antibodies.
Owner:VVB BIO PTE LTD +1

Nectin-4-targeting nano antibody, chimeric antigen receptor CAR and application

The invention belongs to the technical field of biology, and provides a nanometer antibody targeting Nectin-4, and a nucleic acid molecule and an expression vector for coding the nanometer antibody targeting Nectin-4. The invention also provides a chimeric antigen receptor which comprises an extracellular antigen binding domain, a transmembrane domain and an intracellular domain, and the extracellular antigen binding domain is a Nectin-4 nano antibody; the invention also provides a chimeric antigen receptor CAR which contains the nano antibody as scFv and co-expresses CXCR1, a CAR-T cell constructed by the chimeric antigen receptor CAR, and an enhanced CAR-T cell obtained by modifying the CAR-T cell with microbial short-chain fatty acid, so as to improve the infiltration and anti-tumor activity of the CAR-T cell targeting Nectin-4.
Owner:THE FIRST AFFILIATED HOSPITAL OF WANNAN MEDICAL COLLEGE (YIJISHAN HOSPITAL OF WANNAN MEDICAL COLLEGE)

FtACA13 gene derived from tartary buckwheat and expression vector and application of FtACA13 gene

The invention discloses an FtACA13 gene derived from tartary buckwheat as well as an expression vector and application of the FtACA13 gene. According to the invention, the FtACA13 gene is separated from tartary buckwheat; the polynucleotide sequence of the FACA13 gene is as shown in SEQ ID NO.1, and the amino acid sequence of the encoded protein of the FACA13 gene is as shown in SEQ ID NO.2. The FtACA13 gene is genetically transformed into buckwheat to obtain transgenic buckwheat hairy roots with the overexpressed FtACA13 gene, compared with hairy roots of a control group, the growth vigor and fresh weight of the fagopyrum tataricum hairy roots with the overexpressed FtACA13 gene under salt stress are increased, Na < + > accumulation in a plant body is remarkably low, it is proved that the FtACA13 gene can regulate and control the salt stress resistance of the plant, and the salt stress resistance of the fagopyrum tataricum hairy roots is improved. The invention has application prospects in the aspects of cultivating or breeding salt stress resistant plant varieties and the like.
Owner:INSTITUTE OF CROP SCIENCE CHINESE ACADEMY OF AGRICULTURAL SCIENCES

Preparation method and application of anti-human MUC1 antibody

The invention relates to the technical field of biology, in particular to a preparation method and application of an anti-human MUC1 antibody, and provides a recombination system which utilizes an in-vitro B cell culture technology, uses ELISA (enzyme-linked immunosorbent assay) to detect the expression condition of the antibody, performs flow detection on the binding capacity level with cells and performs antibody expression and assembly through an expression vector. The monoclonal antibody with high specificity and strong affinity is screened out, and the immunogenicity is reduced on the basis that the high affinity combined with the antigen is reserved through humanized transformation, so that the monoclonal antibody is favorably applied to immunotherapy of a human body; the anti-human MUC1 antibody prepared by the invention plays an important role in immunotherapy of tumors, and solves the technical problems of insufficient specificity and lower affinity of the MUC1 antibody in the prior art.
Owner:SHANGHAI ENTEBIO PHARMACEUTICAL TECHNOLOGY CO LTD

Monoclonal antibody that specifically binds to TL1a

PCT designated stage expiredWO2025144089A1AntipyreticAnalgesicsAntigenDisease
The present invention relates to the field of biotechnology and medicine, in particular to a monoclonal antibody or antigen-binding fragment thereof that specifically binds to TNF-like ligand 1A (TL1A). The invention further relates to nucleic acids encoding said antibody, expression vectors, host cells and methods for producing same, methods for producing the antibodies according to the invention, pharmaceutical compositions comprising the antibody or antigen-binding fragment thereof according to the invention, as well as to pharmaceutical compositions comprising the antibody or antigen-binding fragment thereof according to the invention and other therapeutically active compounds; to methods for treating TL1A-mediated diseases or disorders, to use of the antibody or antigen-binding fragment thereof or pharmaceutical composition thereof for treating TL1A-mediated diseases or disorders, and to use of the antibody or antigen-binding fragment thereof according to the invention and other therapeutically active compounds for treating TL1A-mediated diseases or disorders.
Owner:JOINT CO BIOCAD

Recombinant IV type collagen as well as preparation method and application thereof

The invention provides recombinant IV-type collagen as well as a preparation method and application thereof, and relates to the technical field of biochemical engineering. The preparation method of the recombinant IV-type collagen comprises the following steps: obtaining a codon from amino acid of the recombinant IV-type collagen, further obtaining a target gene, and synthesizing the target gene onto an expression vector to obtain a plasmid; transferring the plasmid into an expression host, and screening a positive transformant to obtain an expression strain; and culturing the expression strain, and expressing the target protein to obtain the crude recombinant IV-type collagen. The high-purity recombinant IV-type collagen is prepared through a genetic engineering technology, and the recombinant IV-type collagen can significantly down-regulate inflammatory factors and reduce inflammation; heat injury can be reduced by up-regulating heat shock protein; after heat injury, the recombinant IV-type collagen can obviously lower metal matrix protease of heat injury cells, and also can obviously promote gene expression of type I collagen and type III collagen, improve skin elasticity and moisture content and delay skin aging.
Owner:XIAN GIANT BIOGENE TECH CO LTD +1

Chinese orchid flowering regulation gene CsFTL3 as well as encoding protein and application thereof

The invention discloses a Chinese orchid flowering regulation gene CsFTL3 as well as an encoding protein and application thereof, and belongs to the field of plant molecular biology. The gene CsFTL3 for regulating and controlling flowering of Chinese cymbidium is separated from flower bud cDNA (complementary deoxyribonucleic acid) of a Chinese cymbidium variety 'Xiaoxiang', and 174 amino acids are encoded by the gene CsFTL3. Through construction of an expression vector of the CsFTL3 gene, overexpression in wild-type arabidopsis thaliana and heterologous overexpression of the CsFTL3 gene in the arabidopsis thaliana, it is found that bolting and flowering periods of the arabidopsis thaliana are significantly delayed, flower stems are significantly thickened and increased, the number of rosette leaves is significantly increased, and the growth period is prolonged, which indicates that the gene has the function of delaying the flowering time of the arabidopsis thaliana. The Chinese orchid flowering regulation and control gene can be used for molecular mechanism research of orchid flowering time, delay Chinese orchid flowering time, promote plant vegetative growth, prolong whole Chinese orchid viewing time and promote Chinese orchid genetic improvement and variety breeding.
Owner:ENVIRONMENTAL HORTICULTURE RES INST OF GUANGDONG ACADEMY OF AGRI SCI

Gene KWE2 for regulating corn ear grain weight and yield, encoded protein, indel1 marker, expression vector and use thereof in plant trait improvement

Provided are a gene KWE2 for regulating corn car grain weight and yield, a protein encoding same, and an expression vector thereof. Further provided are an InDel1 marker of the gene KWE2 for regulating corn car grain weight and yield, and the use thereof in plant trait improvement.
Owner:HENAN AGRICULTURAL UNIVERSITY

Application of brassica napus BnC05ERF378 gene in improving waterlogging resistance of plants

The invention discloses an application of a rape BnC05ERF378 gene in improving the waterlogging resistance of a plant. The nucleotide sequence of the rape BnC05ERF378 gene is as shown in SEQ ID NO. 1. According to the invention, a brand new stain-resistant gene BnC05ERF378 is cloned from rape for the first time, and is transferred into arabidopsis thaliana to construct a pure line plant and complete stain resistance identification. Experimental results show that the growth state of the transgenic BnC05ERF378 gene arabidopsis thaliana is remarkably superior to that of a wild type after waterlogging treatment, the transgenic BnC05ERF378 gene arabidopsis thaliana can normally bolt, the survival rate is increased from 12.5% to 37.5%, it is fully proved that the gene can enhance the survivability of the plant in a waterlogging environment by regulating the response mechanism of the plant to waterlogging stress, and the survival rate of the plant is increased from 12.5% to 37.5%. And a key guarantee is provided for stable growth of plants under high-humidity, waterflooding and other adverse conditions. According to the discovery and application of the waterlogging-resistant gene BnC05ERF378 disclosed by the invention, a clear functional gene target is provided for improvement of waterlogging resistance of crops. By constructing an expression vector containing the gene and combining mature technologies such as agrobacterium transformation, the gene can be stably introduced into a target plant, and a pure transgenic plant is obtained.
Owner:OIL CROPS RES INST CHINESE ACAD OF AGRI SCI

Method for improving citrus yellow vein disease resistance by using ClPsaN gene

The invention discloses a method for improving citrus yellow vein disease resistance by using a ClPsaN gene. The method comprises the following steps: (1) cloning a VIGS fragment of the citrus ClPsaN gene; (2) constructing two VIGS expression vectors of TRV and CLBV; and (3) transforming the citrus by the VIGS expression vector to obtain a citrus ClPsaN gene silenced VIGS plant. According to the invention, the VIGS vector of the Citrus ClPsaN gene is constructed, and then the Citrus is transformed, so that the obtained Citrus plant can show obvious resistance to the Citrus yellow vein clearing virus, the titer of the Citrus yellow vein clearing virus can be reduced by 22-34%, the accumulation amount of the virus protein is reduced by 35-50%, and the attack degree of the Citrus yellow vein clearing virus is obviously reduced; the TRV silencing of the citrus ClPsaN gene does not influence the phenotype of a citrus plant, and the citrus ClPsaN gene can be used as a candidate gene for citrus yellow vein disease resistance breeding together with a plurality of citrus yellow vein disease-resistant and susceptible genes by utilizing the cooperation of VIGS silencing, RNA interference, gene editing and other technologies.
Owner:GERMPLASM INNOVATION GRAND SCIENCE CENTER OF WESTERN CHINA (CHONGQING) SCIENCE CITY +1

Recombinant collagen III and application thereof in preparation of gel

The invention relates to the technical field of biology, and particularly discloses a recombinant collagen III and application thereof in preparation of gel. The recombinant collagen III is designed by optimizing functional area sequences of human I-type and III-type collagen, the amino acid sequence is shown as SEQ ID No.2, and the recombinant collagen III has the characteristics of high stability, good hydrophilicity and low immunogenicity. The preparation method comprises the steps of expression vector construction, escherichia coli induced expression, affinity chromatography purification and renaturation. The recombinant collagen III can be prepared into a gel dressing and comprises sodium alginate, methylparaben and other components. Experiments show that the gel can effectively promote cell proliferation and has no cytotoxicity; in a mouse skin injury model, the collagen can relieve inflammation, accelerate wound healing and inhibit scar formation, and the effect of the collagen is superior to that of natural human III-type collagen. The invention provides a safe and efficient novel material for wound repair, and is suitable for medical dressings and tissue engineering.
Owner:GUANGXI XIEJIAN BIOTECHNOLOGY CO LTD

Method for rapidly synthesizing creatine in plant

The invention discloses a method for rapidly synthesizing creatine in a plant, and belongs to the technical field of gene engineering. The method comprises the following steps: selecting CDS sequences of two genes HsAGAT and HsGAMT, and carrying out chemical synthesis; constructing a tobacco transient expression vector of the gene, and transforming escherichia coli; transferring the correct pEAQ vector plasmid into agrobacterium by adopting a transient transformation method, and injecting an agrobacterium solution containing expression vectors of two genes into the Bensi tobacco leaves at the same time; and collecting the injected tobacco leaves, and extracting creatine. The invention creates a new way for creatine biosynthesis, avoids the use of various organic reagents in the creatine production process, saves the cost, is green and environment-friendly, integrates the creatine production process and the plant product production process, overcomes the difficulty that the chemically synthesized creatine is bitter in taste and is difficult to be used as a food additive, and improves the quality of the creatine. And a technical foundation is laid for constructing plant products rich in creatine.
Owner:ZHEJIANG UNIV

Lysine decarboxylase mutant and application thereof in synthesis of pentamethylene diamine

The invention discloses a high-efficiency lysine decarboxylase mutant and an application of the high-efficiency lysine decarboxylase mutant in synthesis of pentamethylene diamine. A series of mutants including a single mutant (such as N218G, T222V, C244P and the like), a double mutant and a three mutant are obtained by carrying out multi-site mutation on wild type lysine decarboxylase (SEQ ID NO.2) from Klebsiella grimontii. The catalytic efficiency of the mutant is remarkably improved, and the activity of the mutant is improved by 5.0-10.2 times compared with that of a wild type enzyme. According to the method disclosed by the invention, the substrate conversion rate of 99% or above can be realized within 2 hours through an optimized process of constructing an expression vector and a genetically engineered bacterium, inducing expression of lysine decarboxylase and synthesizing 1, 5-pentanediamine by utilizing a whole-cell catalysis technology. Compared with a traditional chemical method and a natural enzyme method, the method disclosed by the invention has the advantages of simplified process, high catalytic efficiency, low production cost and the like, and is suitable for producing bio-based 1, 5-pentamethylene diamine and nylon 56 salt.
Owner:MEIBANG MEIHE BIOTECHNOLOGY CO LTD

Application of soybean GmWRKY40 gene in soybean breeding

The invention provides application of a soybean GmWRKY40 gene in soybean breeding, and belongs to the technical field of functional gene breeding. The nucleotide sequence of the soybean GmWRKY40 gene provided by the invention is as shown in SEQ ID NO: 1. According to the invention, the GmWRKY40 gene is constructed into a skeleton expression vector to obtain a recombinant vector, and the recombinant vector is transferred into soybean under the mediation of agrobacterium tumefaciens to obtain a transgenic plant with stable overexpression of the GmWRKY40 gene. Detection results show that overexpression of the GmWRKY40 gene can significantly improve the grain isoflavone content and the protein oil content of the transgenic soybean, improve the soybean quality and increase the soybean grain yield at the same time. Therefore, the soybean GmWRKY40 gene can be used for developing new varieties of high-quality soybeans.
Owner:NORTHEAST AGRICULTURAL UNIVERSITY

Neutralizing monoclonal antibody of anti-pseudorabies virus gD protein, hybridoma cell and application thereof

The invention relates to an anti-PRV gD (pseudorabies virus gD) protein neutralizing monoclonal antibody, a hybridoma cell and application of the anti-PRV gD protein neutralizing monoclonal antibody. The anti-PRV gD neutralizing monoclonal antibody is prepared by constructing a PRV gD eukaryotic expression vector, transduction the PRV gD eukaryotic expression vector into a CHO (Chinese hamster ovary) cell for expression and then carrying out animal immunization by taking a PRV gD recombinant protein and an attenuated live vaccine as immunogens. The neutralizing monoclonal antibody or hybridoma cell provided by the invention lays a foundation for the development of a rapid detection technology of the pseudorabies virus and the gD protein thereof, has wide research and application values and commercial use values in immunodetection related to the pseudorabies virus, and has important guiding significance for vaccine development based on the pseudorabies virus.
Owner:ZHENGZHOU UNIV +1

Application of PavERF110 gene in regulating and controlling ripening direction of sweet cherry fruits

The invention provides an application of a PavERF110 gene in regulating and controlling the ripening direction of sweet cherry fruits, and belongs to the technical field of molecular breeding. The nucleotide sequence of the PavERF110 gene is as shown in SEQ ID NO.1, and the amino acid sequence of the encoded protein of the PavERF110 gene is as shown in SEQ ID NO.2. The invention also provides an overexpression vector and a VIGS gene silencing vector constructed by the gene, a construction method of the overexpression vector and the VIGS gene silencing vector, and a recombinant microorganism containing the vectors. Engineering bacteria containing related carriers are injected and infected at the equator of the fruits 25 days after the sweet cherries blossom, and it is found that overexpression of the PavERF110 gene can accelerate fruit coloring and increase the expression level of the mature related genes. New technical support and theoretical basis are provided for sweet cherry fruit quality improvement and ripening regulation, market requirements can be met, and meanwhile understanding of a fruit ripening transcription regulation mechanism is deepened.
Owner:SICHUAN AGRI UNIV

Monoclonal antibody for resisting staphylococcus aureus iron ion regulatory surface determinant B protein and application thereof

The invention discloses a monoclonal antibody for resisting staphylococcus aureus iron ion regulatory surface determinant B protein and application of the monoclonal antibody. Amino acid of a structural domain recognized by the monoclonal antibody is shown as SEQ ID NO.1. The monoclonal antibody is generated by culturing a host cell of an expression vector, the generated monoclonal antibody is secreted into supernate, and the supernate is secreted into the staphylococcus aureus iron ion regulatory surface determinant B protein to obtain the staphylococcus aureus iron ion regulatory surface determinant B. The staphylococcus aureus iron ion regulatory surface determinant B protein. Purifying through a chromatography technology; the obtained antibody can be used for treating septicopyemia caused by staphylococcus aureus / MRSA infection, and has important significance in preventing and treating staphylococcus aureus infection.
Owner:ARMY MEDICAL UNIV